Kidney stones do not directly trigger blood clots the way a broken bone or major surgery might, but the two conditions are more connected than most people realize. People with a history of kidney stones face a measurably higher risk of cardiovascular events including heart attack and stroke, and surgical procedures to remove stones carry a small but real risk of deep vein thrombosis or pulmonary embolism. The relationship runs through shared biology: the same metabolic conditions that promote stone formation also damage blood vessels and shift the body toward a more clot-prone state.
Blood Clots After Kidney Stone Surgery
The most straightforward way a kidney stone can lead to a blood clot is through the surgery used to treat it. Percutaneous nephrolithotomy, the procedure used for larger stones, requires the patient to lie prone (face down) under general anesthesia, sometimes for hours. That combination of immobility, positioning, and tissue trauma creates conditions that favor clot formation in the deep veins of the legs, which can then travel to the lungs as a pulmonary embolism. Case reports document this happening even in otherwise healthy patients. One published case involved a 44-year-old man with no prior health problems who developed a life-threatening pulmonary embolism the day after his procedure, requiring emergency clot-dissolving treatment in the cardiac care unit.1PubMed Central. Pulmonary Embolism following Percutaneous Nephrolithotomy: An Uncommon and Life-Threatening Complication
The risk is considered uncommon, but it is serious enough that surgeons routinely take preventive steps. These often include compression stockings during and after the procedure, early mobilization (getting the patient walking as soon as safely possible), and sometimes blood-thinning medication for patients at higher baseline risk. Less invasive stone procedures like ureteroscopy and shockwave lithotripsy involve shorter operating times and faster recovery, which makes blood clots less likely but does not eliminate the possibility entirely, especially in people who are obese, older, or have a personal history of clotting problems.
Kidney Stones and Cardiovascular Events
Beyond surgical complications, a growing body of population-level research shows that people who form kidney stones are more likely to experience heart attacks and strokes down the road, even after accounting for the usual suspects like high blood pressure, diabetes, and smoking. A large cohort study found that people with at least one kidney stone had roughly 40% higher odds of a subsequent heart attack, and about 26% higher odds of stroke, compared with people who never had stones.2PubMed Central. Kidney stones and cardiovascular events: a cohort study
A separate nationwide study looking specifically at stroke found that the association was strongest in younger adults. People aged 20 to 34 with kidney stones had nearly 50% higher stroke risk than their stone-free peers, whereas in older age groups the difference was smaller.3PubMed Central. Association Between Kidney Stones and Risk of Stroke: A Nationwide Population-Based Cohort Study That pattern is striking because younger adults generally have very low stroke risk, so a meaningful increase in that group suggests something beyond the usual age-related vascular wear and tear.
More recent work using both observational data and genetic analysis found that kidney stone disease was associated with nearly double the odds of heart attack in a sample of over 7,000 U.S. adults. The genetic analysis supported a causal link between kidney stones and coronary heart disease, heart attack, hypertension, and ischemic stroke.4PLOS ONE. Kidney stone disease increases the risk of cardiovascular events Strokes and heart attacks involve clots forming inside blood vessels, so while kidney stones are not directly “causing blood clots” in the traditional sense, they appear to be part of the same metabolic picture that makes dangerous clots more likely.
Why Kidney Stones and Blood Vessel Disease Share Biology
The overlap between kidney stones and cardiovascular problems is not a coincidence. Researchers have been building a case that the mineral deposits forming inside the kidney and the calcified plaques building up inside arteries are driven by remarkably similar processes. Most kidney stones begin on tiny calcium phosphate deposits called Randall’s plaques, which form at the tip of the kidney’s inner tissue. These plaques share structural features with vascular calcification: they contain calcium phosphate crystals embedded in a matrix of proteins, lipids, and cellular debris that looks a lot like what you would find in a hardened arterial plaque.5Nature Reviews Nephrology. Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation
This similarity has led to what some researchers call a “vascular theory” of kidney stone formation. The idea is that the same kind of initial injury to small blood vessels in the kidney that initiates vascular calcification elsewhere in the body is also what kicks off Randall’s plaque formation and, eventually, stone growth.6PubMed. Vascular theory of the formation of Randall plaques If this theory holds up, it would mean that kidney stones are not just a plumbing problem in the urinary tract. They would be an early signal that the body’s blood vessels are under stress, which would help explain why stone formers face higher cardiovascular risk years or decades later.
Metabolic Syndrome Ties the Two Together
One of the clearest links between kidney stones and cardiovascular clot risk is metabolic syndrome, the cluster of conditions that includes high blood pressure, high blood sugar, excess abdominal fat, and abnormal cholesterol levels. People with metabolic syndrome are more likely to form kidney stones, and the relationship scales with severity. A large study found that having metabolic syndrome raised the odds of developing kidney stones by about 30%, and people who met all five criteria of the syndrome had roughly double the odds of stones compared with people who had none of the traits.7PubMed Central. Metabolic Syndrome Increases the Risk of Kidney Stone Disease: A Cross-Sectional and Longitudinal Cohort Study
Metabolic syndrome is also one of the strongest drivers of atherosclerosis, the buildup of fatty and calcified plaques in arteries that eventually rupture and cause clots. So the person whose body chemistry promotes stone formation is, in many cases, the same person whose body chemistry is silently damaging blood vessel walls and setting the stage for a heart attack or stroke. This does not mean that every stone former will have a cardiovascular event, but it means that a kidney stone diagnosis is worth taking as a broader metabolic signal rather than an isolated urinary problem.
Among the individual components of metabolic syndrome, high blood pressure was the single strongest predictor of kidney stone formation in that same study. That matters because hypertension itself is a major contributor to blood vessel damage and clot formation. If you have kidney stones and high blood pressure, the combination deserves attention from your doctor beyond just managing the stone.
Oxalate, Endothelial Damage, and Clotting Risk
The most common type of kidney stone is made of calcium oxalate, and oxalate itself may be part of the vascular problem. Animal research shows that a high-oxalate diet, the kind that promotes calcium oxalate stones, does more than just affect the kidneys. In one study, mice on a high-oxalate diet experienced a nearly 50% drop in kidney filtration, a 23% increase in blood pressure, and significant damage to the endothelium, the thin layer of cells lining the inside of blood vessels.8Biochimica et Biophysica Acta – Molecular Basis of Disease. High-oxalate diet-induced kidney injury impairs AVF remodeling via hypertension, endothelial damage, and immune activation
Endothelial damage is one of the classic triggers for blood clot formation. Healthy endothelial cells actively prevent clots from forming by releasing substances that keep blood flowing smoothly. When those cells are injured, they lose that protective function, and the underlying tissue becomes exposed to circulating blood, triggering the clotting process. The same study found increased immune cell infiltration and vascular calcification in the blood vessels of the high-oxalate animals, both of which compound the clotting risk. This is still early-stage research in animal models, but it provides a biological mechanism that could explain why humans who form oxalate stones seem to face higher cardiovascular danger.
When Infection Complicates the Picture
Kidney stones can also lead to serious infections, and infection is itself a recognized trigger for blood clot formation. When a stone blocks the ureter, urine backs up behind it, creating a warm, stagnant environment where bacteria can multiply rapidly. This can escalate from a simple urinary tract infection to urosepsis, a bloodstream infection that can become life-threatening. In one study of patients with obstructing stones and suspected infection, nearly half had urosepsis at the time they first sought care.9Urology. Obstructing Ureteral Calculi and Presumed Infection: Impact of Antimicrobial Duration and Time From Decompression to Stone Treatment in Developing Urosepsis
Sepsis, regardless of its source, dramatically increases the likelihood of blood clots. The body’s inflammatory response to widespread infection activates the clotting system as part of its defense mechanism, but this can tip over into harmful clotting in the veins and even in small vessels throughout the body. For someone hospitalized with an infected, obstructing kidney stone, the risk of developing a venous blood clot is elevated both from the infection itself and from the immobility that comes with being acutely ill. This is one reason why urgent decompression of the blocked kidney, usually with a temporary stent or drainage tube, is the first priority when an obstructing stone is accompanied by signs of infection.
Blood in the Urine Is Not the Same as a Blood Clot
A common source of confusion is the visible blood that often appears in the urine during a kidney stone episode. Seeing blood can understandably make people worry about blood clots, but hematuria (blood in the urine) and a venous blood clot are completely different things. When a stone scrapes along the lining of the ureter or kidney, it causes small tears that bleed into the urine. This is a local mechanical injury, not a systemic clotting problem. The blood may look alarming, especially if it turns the urine pink, red, or brown, but it typically resolves on its own once the stone passes or is removed.
That said, heavy bleeding into the urinary tract can occasionally produce blood clots within the urinary system itself. These are not the dangerous venous clots that travel to the lungs. They are clumps of coagulated blood that form inside the kidney or bladder and can sometimes block the flow of urine, creating their own form of obstruction. This is more common after kidney procedures like biopsy than during a spontaneous stone episode. In one reported case, a patient developed blood clots inside the kidney’s drainage system after a biopsy, and the resulting blockage had to be cleared with clot-dissolving medication delivered directly through a catheter.10Europe PMC. Ureteral obstruction due to blood clot following percutaneous renal biopsy: resolution with intraureteral streptokinase This kind of clot is a localized plumbing problem rather than the type of clot that causes a pulmonary embolism or stroke.
Who Should Be Most Concerned
Not everyone with a kidney stone needs to panic about blood clots, but certain groups should pay closer attention. People with recurrent stones, especially those who have undergone multiple procedures, appear to be at elevated risk. The stroke study mentioned earlier found that patients who had more than four stone-related surgeries had a dramatically higher stroke risk, suggesting that repeated stones and repeated interventions compound the vascular toll.3PubMed Central. Association Between Kidney Stones and Risk of Stroke: A Nationwide Population-Based Cohort Study
Women with kidney stones may also deserve particular attention. The same study found that women with stones had a statistically significant increase in stroke risk compared with women without stones, while in men the association was not as clear-cut. The reasons for this sex-based difference are not fully understood, but hormonal influences on both stone formation and vascular health are likely part of the explanation.
Young adults with stones are another group that clinicians are increasingly watching. The finding that 20-to-34-year-olds with stones had the sharpest relative increase in stroke risk is a red flag, because it suggests that forming stones at an early age may be an indicator of underlying metabolic or vascular dysfunction that will have consequences far beyond the urinary tract. If you are in your twenties or thirties and have already had a kidney stone, it is worth asking your doctor to check for metabolic syndrome components like blood pressure, fasting glucose, and lipid levels, not just to prevent the next stone but to get ahead of cardiovascular risk.
What Kidney Stone Patients Can Do
The practical message here cuts in two directions. In the short term, if you are having a kidney stone procedure, make sure your surgical team is taking standard clot-prevention measures. Ask about compression devices during and after the operation, and get moving as soon as your surgeon says it is safe. If you have additional clot risk factors like obesity, a history of blood clots, use of oral contraceptives, or recent immobility from travel, mention them before the procedure so your team can adjust their prevention strategy.
In the longer term, treating kidney stones as a metabolic warning sign could pay off significantly. The evidence linking stones to cardiovascular events is strong enough that some researchers have argued kidney stone history should be considered a cardiovascular risk factor in its own right, similar to how we treat conditions like polycystic ovary syndrome as markers of broader metabolic risk. Staying well hydrated, maintaining a healthy weight, controlling blood pressure, and moderating salt and animal protein intake are strategies that reduce both stone recurrence and cardiovascular risk simultaneously. That overlap is not a coincidence; it reflects the shared biology between the two conditions.
Dietary oxalate is worth mentioning briefly, since calcium oxalate is the most common stone type. Foods like spinach, rhubarb, beets, and nuts are high in oxalate, and people who form oxalate stones are often told to moderate their intake. The animal research showing endothelial damage from high oxalate loads adds another reason to take that advice seriously, though it is important not to overcorrect. Calcium-rich foods actually help prevent oxalate absorption in the gut, so cutting dairy in an attempt to avoid “calcium stones” is a common mistake that can backfire in both directions, increasing stone risk and potentially weakening bones. The nuances of dietary stone prevention are worth discussing with a dietitian who specializes in kidney stone management.